Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Sphera Funds Management Ltd.
Form 13F · Q2 2026

Sphera Funds Management Ltd.

CIK 1496201Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$767M
Reported book value
106
Positions
12
Quarters on record
Top 50
Positions

Sphera Funds Management Ltd. — holdings

Top 50 positions of 106, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1TEVA PHARMACEUTICAL INDS LTD Teva Pharmaceutical Inds Ltd1.5M+31.9%$51M6.6%
2MLYS Mineralys Therapeutics Inc1.5M+9.7%$40M5.2%
3TSEM Tower Semiconductor Ltd108,265−25.7%$28M3.7%
4SNDX Syndax Pharmaceuticals Inc1.0M+40.0%$22M2.9%
5BIIB Biogen Inc96,626+4.4%$21M2.7%
6RARE Ultragenyx Pharmaceutical In588,494−27.3%$20M2.6%
7BMRN Biomarin Pharmaceutical Inc328,550+134.8%$19M2.5%
8CYTK Cytokinetics Inc219,987+452.5%$19M2.4%
9BBIO Bridgebio Pharma Inc245,346+0.0%$18M2.4%
10COGT Cogent Biosciences Inc459,340+10.3%$18M2.3%
11NVMI Nova Ltd25,169−52.8%$14M1.8%
12INSM Insmed Inc118,800—$13M1.7%
13MAZE Maze Therapeutics Inc417,564+83.7%$12M1.6%
14AZN Astrazeneca Plc62,530+0.0%$12M1.5%
15SNY Sanofi Sa269,515+0.0%$11M1.5%
16CYBIN INC Cybin Inc1.6M+64.2%$11M1.4%
17LLY Eli Lilly & Co8,040−11.1%$10M1.3%
18MDGL Madrigal Pharmaceuticals Inc17,419+92.7%$9M1.2%
19TRVI Trevi Therapeutics Inc499,029−13.1%$9M1.2%
20ACAD Acadia Pharmaceuticals Inc356,534+39.2%$9M1.2%
21CLDX Celldex Therapeutics Inc New240,868−1.1%$9M1.2%
22RYTM Rhythm Pharmaceuticals Inc80,400—$9M1.2%
23ORIC Oric Pharmaceuticals Inc752,983+40.1%$8M1.1%
24LRCX Lam Research Corp18,470—$8M1.0%
25APPLIED MATLS INC Applied Matls Inc11,040—$8M1.0%
26TNGX Tango Therapeutics Inc254,250−26.0%$8M1.0%
27NVS Novartis Ag50,000+35.1%$8M1.0%
28SOLAR EDGE TECHNOLOGIES 2.25 07/01/2029 Solar Edge Technologies 2.25 07/01/20294.0M+0.0%$8M1.0%
29VOR Vor Biopharma Inc416,417+29.4%$8M1.0%
30ABBV Abbvie Inc30,256+0.0%$8M1.0%
31MRK Merck & Co Inc58,600+20.6%$8M1.0%
32JNJ Johnson & Johnson28,831+0.0%$7M1.0%
33IDYA Ideaya Biosciences Inc196,408—$7M1.0%
34IMTX Immatics N.V720,057+3.4%$7M1.0%
35NVCT Nuvectis Pharma Inc382,945—$7M0.9%
36PFE Pfizer Inc286,000+53.8%$7M0.9%
37HRMY Harmony Biosciences Hldgs In176,663—$6M0.8%
38XENE Xenon Pharmaceuticals Inc105,000−17.3%$6M0.8%
39CLYM Climb Bio Inc483,747+15.4%$6M0.8%
40ZBIO Zenas Biopharma Inc230,834+7.7%$6M0.8%
41NVO Novo-Nordisk A S120,677+0.0%$6M0.8%
42ELVN Enliven Therapeutics Inc112,765−26.4%$6M0.7%
43PRLD Prelude Therapeutics Inc1.0M+82.7%$5M0.7%
44GSK Gsk Plc102,000−16.4%$5M0.7%
45FORTE BIOSCIENCES INC Forte Biosciences Inc249,693+35.0%$5M0.7%
46BIOA Bioage Labs Inc213,671+147.0%$5M0.7%
47SRRK Scholar Rock Hldg Corp94,265+0.0%$5M0.7%
48MSLE Satellos Bioscience Inc652,590+33.4%$5M0.7%
49PALI Palisade Bio Inc2.3M+30.2%$5M0.6%
50ELDN Eledon Pharmaceuticals Inc1.2M−32.8%$5M0.6%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.